XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-based Compensation Expense for Employees and Non-employees

In the accompanying condensed consolidated statements of operations, the Company recognized stock-based compensation expense for its employees and non-employees as follows:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Research and development

 

$

1,776

 

 

$

933

 

 

$

3,439

 

 

$

1,479

 

General and administrative

 

 

1,452

 

 

 

2,684

 

 

 

2,720

 

 

 

3,056

 

Total stock-based compensation

 

$

3,228

 

 

$

3,617

 

 

$

6,159

 

 

$

4,535

 

Schedule of Estimated Grant-date Fair Value of Stock-based Awards Using Black-Scholes Option Pricing Model Assumptions

The fair values of the Company’s stock-based awards granted during the three and six months ended June 30, 2021 and 2020 were estimated as of the grant date using the Black-Scholes option pricing model, based on assumptions as follows:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Expected term (in years)

 

5.3 – 6.1

 

 

5.3 – 7.0

 

 

5.3 – 7.0

 

 

5.3 – 7.0

 

Expected volatility

 

 

83 – 85

%

 

 

88 – 90

%

 

 

83 – 85

%

 

 

88 – 90

%

Risk-free interest rate

 

 

0.8 – 1.1

%

 

 

0.4 – 0.5

%

 

 

0.5 – 1.1

%

 

 

0.4 – 1.2

%

Expected dividend rate

 

 

%

 

 

%

 

 

%

 

 

%

 

Summary of Stock-Based Compensation Activity

A summary of activity under the 2008 Plan, 2015 Plan and 2018 Plan and related information is as follows:

 

 

 

 

 

 

 

Options Outstanding

 

 

 

Shares

Available

for Grant

 

 

Number

of Shares

Outstanding

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Weighted-

Average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value of

Outstanding

Options

(in thousands)

 

Outstanding — December 31, 2020

 

 

1,117,796

 

 

 

4,146,928

 

 

$

19.45

 

 

 

8.84

 

 

$

12,227

 

Awards authorized

 

 

945,139

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(869,460

)

 

 

869,460

 

 

 

16.87

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

(30,218

)

 

 

13.29

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

199,701

 

 

 

(199,701

)

 

 

17.43

 

 

 

 

 

 

 

 

 

Outstanding — June 30, 2021

 

 

1,393,176

 

 

 

4,786,469

 

 

$

19.11

 

 

8.56

 

 

$

26,418

 

Exercisable — June 30, 2021

 

 

 

 

 

 

955,199

 

 

$

39.28

 

 

 

6.10

 

 

$

4,149

 

Vested and expected to vest — June 30, 2021

 

 

 

 

 

 

4,261,231

 

 

$

19.96

 

 

8.48

 

 

$

22,573